CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 5116 | LVS EN 12322:2001/A1:2002 | In vitro diagnostic medical devices - Culture media for microbiology - Performance criteria for culture media | Standarts spēkā |
| 70355 | LVS EN ISO 20776-2:2022 | Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution (ISO 20776-2:2021) | Standarts spēkā |
| 65451 | LVS CEN/TS 17390-3:2020 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 3: Preparations for analytical CTC staining | Standarts spēkā |
| 67446 | LVS CEN/TS 17626:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for human specimen - Isolated microbiome DNA | Standarts spēkā |
| 68789 | LVS EN ISO 20166-4:2021 | Molecular in vitro diagnostic examinations - Specifications for preexamination processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 4: In situ detection techniques (ISO 20166-4:2021) | Standarts spēkā |
| 65452 | LVS CEN/TS 17390-2:2020 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 2: Isolated DNA | Standarts spēkā |
| 70930 | LVS EN ISO 18113-2:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO 18113-2:2022) | Standarts spēkā |
| 68065 | LVS EN ISO 23162:2021 | Basic semen examination - Specification and test methods (ISO 23162:2021) | Standarts spēkā |
| 74322 | LVS CEN ISO/TS 5798:2023 | In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022) | Standarts spēkā |
| 75465 | CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
Displaying 51-60 of 272 results.